Quantcast

Integra LifeSciences Updates 2018 Outlook - Quick Facts


Shutterstock photo


(RTTNews.com) - Integra LifeSciences Holdings Corp. ( IART ) raised the low end of its full-year 2018 total revenue guidance by $5 million to a new range of $1.475 billion to $1.490 billion. The company also raised the low end of its full-year 2018 GAAP earnings per share guidance range to $0.71 to $0.77, and adjusted earnings per share guidance range to $2.36 to $2.42, an increase of two cents. The company continues to expect full-year 2018 organic revenue growth to be approximately 5.0%, consistent with prior guidance.

For the second quarter of 2018, adjusted earnings per share was $0.60, an increase of 33.3% over the prior year's quarter. Total revenues were $366.2 million, reflecting an increase of 29.8% over the second quarter of 2017. Sales in the Codman Specialty Surgical segment increased 49.8% compared to the second quarter of 2017, driven by the Codman acquisition and strong performance in the Dural Access and Repair and Advanced Energy businesses. Total organic revenues increased 3.4% over the second quarter of 2017, excluding acquisitions, divestitures and the effect of currency exchange rates.


Read the original article on RTTNews (http://www.rttnews.com/2917613/integra-lifesciences-updates-2018-outlook-quick-facts.aspx)


For comments and feedback: contact editorial@rttnews.com




This article appears in: Fundamental Analysis , Stocks , World Markets , Earnings
Referenced Symbols: IART



More from RTT News

Subscribe






See All RTT news











Research Brokers before you trade

Want to trade FX?